1-hexadecyl-2-acetyl-glycero-3-phosphocholine and No-Reflow Phenomenon

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with No-Reflow Phenomenon in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, Z; Li, C; Liu, H; Liu, Y; Ren, J	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and No-Reflow Phenomenon

Article	Year
Protective effect of dexmedetomidine against myocardial ischemia-reperfusion injury in rabbits. Acta cirurgica brasileira, 2018, Volume: 33, Issue:1 Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Disease Models, Animal; Endothelin-1; Heart Rate; Hemodynamics; Male; Myocardial Reperfusion Injury; No-Reflow Phenomenon; Platelet Activating Factor; Rabbits; Random Allocation; Reference Values; Reproducibility of Results; Thromboxane A2; Treatment Outcome	2018

Article

Year

Protective effect of dexmedetomidine against myocardial ischemia-reperfusion injury in rabbits.

Acta cirurgica brasileira, 2018, Volume: 33, Issue:1

Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Disease Models, Animal; Endothelin-1; Heart Rate; Hemodynamics; Male; Myocardial Reperfusion Injury; No-Reflow Phenomenon; Platelet Activating Factor; Rabbits; Random Allocation; Reference Values; Reproducibility of Results; Thromboxane A2; Treatment Outcome

2018